[go: up one dir, main page]

MX2019009659A - Improved dose of baloxavir marboxil for pediatric patients. - Google Patents

Improved dose of baloxavir marboxil for pediatric patients.

Info

Publication number
MX2019009659A
MX2019009659A MX2019009659A MX2019009659A MX2019009659A MX 2019009659 A MX2019009659 A MX 2019009659A MX 2019009659 A MX2019009659 A MX 2019009659A MX 2019009659 A MX2019009659 A MX 2019009659A MX 2019009659 A MX2019009659 A MX 2019009659A
Authority
MX
Mexico
Prior art keywords
pediatric patients
improved dose
baloxavir marboxil
marboxil
baloxavir
Prior art date
Application number
MX2019009659A
Other languages
Spanish (es)
Inventor
Buck Stefan De
Toshihiro Wajima
Toru Ishibashi
Sylvie Retout
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to MX2019009659A priority Critical patent/MX2019009659A/en
Publication of MX2019009659A publication Critical patent/MX2019009659A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a method for treating an influenza virus infection by administering an effective amount of a compound having the formulas I and II or a pharmaceutically acceptable salt thereof.
MX2019009659A 2019-08-13 2019-08-13 Improved dose of baloxavir marboxil for pediatric patients. MX2019009659A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2019009659A MX2019009659A (en) 2019-08-13 2019-08-13 Improved dose of baloxavir marboxil for pediatric patients.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2019009659A MX2019009659A (en) 2019-08-13 2019-08-13 Improved dose of baloxavir marboxil for pediatric patients.

Publications (1)

Publication Number Publication Date
MX2019009659A true MX2019009659A (en) 2021-02-15

Family

ID=85227471

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019009659A MX2019009659A (en) 2019-08-13 2019-08-13 Improved dose of baloxavir marboxil for pediatric patients.

Country Status (1)

Country Link
MX (1) MX2019009659A (en)

Similar Documents

Publication Publication Date Title
ZA202500439B (en) Therapeutic compounds for hiv virus infection
ZA202002139B (en) Combination pharmaceutical agents as rsv inhibitors
BR112022000019A2 (en) Formula compound, pharmaceutical composition and cancer treatment method
SA521431048B1 (en) Pyrrolidone compounds
MX2020007633A (en) MACROCYCLIC PEPTIDES AGAINST ACINETOBACTER BAUMANNII.
EA201892034A1 (en) ELIMINATION OF HEPATITIS B VIRUS WITH THE HELP OF ANTI-VIRUS AGENTS
MD20150092A2 (en) Amide derivatives for the treatment of HIV infection
CR20210207A (en) Inhibitors of human immunodeficiency virus replication
PH12018501001A1 (en) Therapeutic compositions for treatment of human immunodeficiency virus
WO2020033838A3 (en) Treatment of egfr-mutant cancer
MX2022007911A (en) Method of treating virus infection using a tlr7 agonist.
PH12021550632A1 (en) Monomer and multimeric anti-hbv agents
PH12021550713A1 (en) Medicament for the treatment of chronic cough
BR112021025764A2 (en) Pyrimidine derivative that inhibits the growth of cancer cells and medicinal use thereof
EA202091604A1 (en) INHIBITION OF THE ION CHANNEL A1 WITH A TRANSITOR RECEPTOR POTENTIAL
PH12020551117A1 (en) Compositions for preventing or treating uveitis
NZ758839A (en) Glycopeptide derivative compounds and uses thereof
MX2019001412A (en) 9-aminomethyl minocycline compounds and uses thereof.
PH12015502128A1 (en) Novel dosing regimens of celgosivir for the treatment of dengue
PH12022551160A1 (en) Treatment and prevention of dengue disease
MX2019009659A (en) Improved dose of baloxavir marboxil for pediatric patients.
EA202193211A1 (en) TREATMENT OF SYNUCLEOPATHIES
MX2023014898A (en) ADVANTAGEOUS ANTI-HCV COMBINED THERAPY.
PH12020551620A1 (en) Compositions for preventing or treating dry eye
WO2016178987A3 (en) Preventing or treating viral infection by inhibition of the histone methyltransferase ezh1 or ezh2